Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 14551 - 14575 of 15247 in total

Barusiban

Barusiban has been used in trials studying the treatment of Infertility and In Vitro Fertilisation (IVF) Treatment.
Investigational
Matched Iupac: … -16-[(1H-indol-3-yl)methyl]-N-methyl-6,9,12,15,18-pentaoxo-1-thia-5,8,11,14,17-pentaazacycloicosane-4- …
Matched Description: … Barusiban has been used in trials studying the treatment of Infertility and In Vitro Fertilisation (IVF …

Vobarilizumab

Vobarilizumab is under investigation in clinical trial NCT02101073 (ALX-0061 Phase I Bioavailability Study in Healthy Volunteers).
Investigational
Matched Description: … Study in Healthy Volunteers). ... Vobarilizumab is under investigation in clinical trial NCT02101073 (ALX-0061 Phase I Bioavailability …

Mureletecan

Mureletecan is under investigation in clinical trial NCT00004076 (PNU 166148 in Treating Patients With Metastatic Solid Tumors).
Investigational
Matched Description: … Mureletecan is under investigation in clinical trial NCT00004076 (PNU 166148 in Treating Patients With …

Hydrogen

Hydrogen is under investigation in clinical trial NCT02830854 (Molecular Hydrogen for Cognitive Function and Performance in Elderly).
Investigational
Matched Description: … and Performance in Elderly). ... Hydrogen is under investigation in clinical trial NCT02830854 (Molecular Hydrogen for Cognitive Function …

Futuximab

Futuximab is under investigation in clinical trial NCT01955473 (Japanese Phase 1 Trial of Sym004 in Solid Tumors).
Investigational
Matched Description: … Futuximab is under investigation in clinical trial NCT01955473 (Japanese Phase 1 Trial of Sym004 in Solid …

DAS-181

DAS-181 is under investigation in clinical trial NCT00527865 (Single Dose Escalating Study of DAS181 in Adults).
Investigational
Matched Description: … in Adults). ... DAS-181 is under investigation in clinical trial NCT00527865 (Single Dose Escalating Study of DAS181 …

Bamifylline

Bamifylline is a selective A1 adenosine receptor antagonist.
Experimental
Matched Description: … Bamifylline is a selective A1 adenosine receptor antagonist. …
Matched Salts cas: … 20684-06-4 …

Protego-PD

Protego-PD is a post-delivery placental extract.
Investigational
Matched Description: … Protego-PD is a post-delivery placental extract. …

MK-0482

MK-0482 is a novel humanized IgG4 monoclonal antibody targeting the immunoglobulin-like transcript (ILT) 3.
Investigational
Matched Description: … MK-0482 is a novel humanized IgG4 monoclonal antibody targeting the immunoglobulin-like transcript (ILT …

PLG-0206

PLG-0206 is a peptide antibiotic under investigation for the treatment of periprosthetic joint infections.
Investigational
Matched Description: … PLG-0206 is a peptide antibiotic under investigation for the treatment of periprosthetic joint infections …

Murepavadin

Murepavadin is under investigation in clinical trial NCT02110459 (Pharmacokinetics and Safety of POL7080 in Patients With Renal Impairment).
Investigational
Matched Description: … in Patients With Renal Impairment). ... Murepavadin is under investigation in clinical trial NCT02110459 (Pharmacokinetics and Safety of POL7080 …

Telisotuzumab

Telisotuzumab is under investigation in clinical trial NCT01472016 (Study of ABT-700 in Subjects With Advanced Solid Tumors).
Investigational
Matched Description: … Telisotuzumab is under investigation in clinical trial NCT01472016 (Study of ABT-700 in Subjects With …

Enoblituzumab

Enoblituzumab is under investigation in clinical trial NCT02982941 (Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors).
Investigational
Matched Description: … Enoblituzumab is under investigation in clinical trial NCT02982941 (Enoblituzumab (MGA271) in Children …

BPI-3016

BPI-3016 is under investigation in clinical trial NCT03188848 (Dose Escalating Study of BPI-3016 in Healthy Subjects).
Investigational
Matched Description: … BPI-3016 is under investigation in clinical trial NCT03188848 (Dose Escalating Study of BPI-3016 in Healthy …

STG-001

STG-001 is under investigation in clinical trial NCT04489511 (Study of STG-001 in Subjects With Stargardt Disease).
Investigational
Matched Description: … STG-001 is under investigation in clinical trial NCT04489511 (Study of STG-001 in Subjects With Stargardt …

Shark liver oil

Shark oil is extracted from the livers of sharks, which can account for up to 25% of their total body weight. The 3 main targeted species are the deep sea shark (Centrophorus squamosus), the dogfish (Sqaulus acanthias), and the basking shark (Cetorhinus maximus). Shark oil is a rich source of...
Experimental
Matched Description: … The potential benefit of shark oil has been experimented in different therapeutic implications, where ... Shark oil is a rich source of alkylglycerols and squalene, with relatively low amounts of n-3 polyunsaturated …

TEL540-548

TEL540-548 is a recombinant peptide consisting of the amino acid residues 540 to 548 of the human telomerase reverse transcriptase (hTERT).
Investigational
Matched Description: … TEL540-548 is a recombinant peptide consisting of the amino acid residues 540 to 548 of the human telomerase …

Dihydroxyacetone phosphate

Dihydroxyacetone phosphate is an important intermediate in lipid biosynthesis and in glycolysis. Dihydroxyacetone phosphate has been investigated for the treatment of Lymphoma, Large-Cell, Diffuse.
Investigational
Matched Description: … Dihydroxyacetone phosphate is an important intermediate in lipid biosynthesis and in glycolysis. …

10-hydroxycamptothecin

10-hydroxycamptothecin is under investigation in clinical trial NCT00956787 (Study of AR-67 (DB-67) in Myelodysplastic Syndrome (MDS)).
Investigational
Matched Description: … 10-hydroxycamptothecin is under investigation in clinical trial NCT00956787 (Study of AR-67 (DB-67) in …

Etirinotecan pegol

Etirinotecan pegol is under investigation in clinical trial NCT01663012 (Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma).
Investigational
Matched Description: … Etirinotecan pegol is under investigation in clinical trial NCT01663012 (Phase II NKTR-102 In Bevacizumab-Resistant …

ELX-02

ELX-02 is under investigation in clinical trial NCT03309605 (Phase 1 Study of ELX-02 in Healthy Adult Subjects).
Investigational
Matched Description: … ELX-02 is under investigation in clinical trial NCT03309605 (Phase 1 Study of ELX-02 in Healthy Adult …

Balixafortide

Balixafortide is under investigation in clinical trial NCT03786094 (Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer).
Investigational
Matched Description: … Balixafortide is under investigation in clinical trial NCT03786094 (Pivotal Study in HER2 Negative, Locally …

Tabituximab barzuxetan yttrium Y-90

A version of tabituximab barzuxetan radiolabeled with yttrium-90.
Investigational
Matched Description: … A version of [tabituximab barzuxetan] radiolabeled with yttrium-90. …

Cortivazol

Cortivazol is under investigation in clinical trial NCT00804895 (Cluster Headache Cortivazol Injection (CHCI)).
Investigational
Matched Iupac: … dihydroxy-2,11,16,18-tetramethyl-7-phenyl-6,7-diazapentacyclo[11.7.0.0^{2,10}.0^{4,8}.0^{14,18}]icosa-4( …
Matched Description: … Cortivazol is under investigation in clinical trial NCT00804895 (Cluster Headache Cortivazol Injection …

Sulopenem etzadroxil

Sulopenem etzadroxil is under investigation in clinical trial NCT03354598 (Oral Sulopenem-etzadroxil/probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women).
Investigational
Matched Iupac: … (1R,3S)-3-{[(5R,6S)-2-({[(2-ethylbutanoyl)oxy]methoxy}carbonyl)-6-[(1R)-1-hydroxyethyl]-7-oxo-4-thia- …
Matched Description: … probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women). ... Sulopenem etzadroxil is under investigation in clinical trial NCT03354598 (Oral Sulopenem-etzadroxil/ …
Displaying drugs 14551 - 14575 of 15247 in total